Reduced levels of antiinflammatory cytokines in patients with chronic...
Chronic widespread pain, a common medical condition, can be difficult to treat and is often associated with fatigue, poor sleep and depression.
View ArticleInfluence of inflammatory polyarthritis on cancer incidence and survival
Patients with rheumatoid arthritis (RA), a chronic inflammatory autoimmune disease, have a high risk of death from disease - at least double the risk of the general population, studies overwhelmingly...
View ArticleGene expression differences could bring better classification and treatment...
Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA). Eventually such findings could enable...
View ArticleStudy indicates dogs make excellent models for studying human genetic disorders
In the new Swedish-Finnish study, published in Nature Genetics, the researchers identified five loci that predispose to an SLE-related disease in Nova Scotia duck tolling retrievers.
View ArticleFurther trials needed to determine clinical application of Abatacept in SLE
Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept failed...
View ArticlePLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper...
View ArticleJuvenile Arthritis patients may have difficulties achieving educational success
As children with juvenile idiopathic arthritis (JIA) grow into adulthood, disability due to disease may adversely affect their ability to achieve educational success. Findings published in Arthritis...
View ArticleBiologic treatments reduce mortality risk in patients with rheumatoid arthritis
According to a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, patients with rheumatoid arthritis (RA) who are prescribed biologic treatments have a...
View ArticleRSAS honors Feinstein Institute scientist with Crafoord Prize for genetic...
The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen , MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his...
View ArticleLearned helplessness role in inflammatory polyarthritis revealed
Learned helplessness is a modifiable risk factor that can significantly influence disease outcome in patients with inflammatory polyarthritis, UK clinicians believe.
View ArticleStudy indicates dogs make excellent models for studying human genetic disorders
In the new Swedish-Finnish study, published in Nature Genetics, the researchers identified five loci that predispose to an SLE-related disease in Nova Scotia duck tolling retrievers.
View ArticleFurther trials needed to determine clinical application of Abatacept in SLE
Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept failed...
View ArticlePLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper...
View ArticleJuvenile Arthritis patients may have difficulties achieving educational success
As children with juvenile idiopathic arthritis (JIA) grow into adulthood, disability due to disease may adversely affect their ability to achieve educational success. Findings published in Arthritis...
View ArticleBiologic treatments reduce mortality risk in patients with rheumatoid arthritis
According to a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, patients with rheumatoid arthritis (RA) who are prescribed biologic treatments have a...
View ArticleRSAS honors Feinstein Institute scientist with Crafoord Prize for genetic...
The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen , MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his...
View ArticleLearned helplessness role in inflammatory polyarthritis revealed
Learned helplessness is a modifiable risk factor that can significantly influence disease outcome in patients with inflammatory polyarthritis, UK clinicians believe.
View ArticleAnti-CPP presence in bloodstream of RA patients correlates with drug response
The results of a study presented today at the European League Against Rheumatism Annual Congress showed that the presence of an antibody (anti-CPP ) in the bloodstream of patients with rheumatoid...
View ArticleResearchers reveal potential therapeutic treatment for alphavirus infections
Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment for the global battle against...
View ArticleSurprising discovery about BH4 may rekindle interest in once-promising pathway
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, PhD, and chemist Kai Johnsson, PhD, his fellow co-founder at Quartet Medicine, believed they held the key to...
View Article